谐波改变在多大比例上可由’血管硬化/后负荷’而非’器官共振’解释:机制拆分研究

Written by

in

Language

Evidence level: B

脉诊谐波谱(C1-C10)的每一次改变,都可能只是血管硬化与后负荷的全局”背景噪声”——要证明”一脏一谐波”真实存在,必须先量化这两条路径各自的贡献比例。

正文

中医脉诊的频域化研究有一个隐秘的软肋:桡动脉脉搏波的谐波成分(第一至第十谐波 C1-C10)确实携带疾病信息——糖尿病患者的 C1、C5 显著偏移(PMID 32733859),冠心病患者的谐波能量比值可辅助判别——但”谐波变了”不等于”对应的脏腑出了问题”。脉搏波是心脏射血产生的压力波沿动脉树传播、叠加反射波后的总成,它的频谱形状由三类因素共同决定:①血管壁本身的机械性质(弹性/硬度,即”血管硬化”路径);②心室射血与动脉树耦合产生的”后负荷/波反射”结构(反射波强度与返回时机);③各器官供血血管床的频率选择性(即”器官共振”路径)。前两条是全身性、随年龄与疾病单调变化的”全局背景”;第三条才是”一脏一谐波”假设赖以成立的”器官特异前景”。

问题在于:现有文献几乎都只报告”谐波谱与某疾病显著相关”,却从不拆分这三类因素的贡献比例。于是出现了一个尖锐的替代解释:如果谐波谱的大部分变异其实由血管硬化与后负荷驱动,那么”谐波-脏腑对应”就只是”谐波-血管老化”的伪影,器官共振假说需要被大幅降级。

这条”反方”路径的证据链其实非常扎实。首先,谐波谱的全局形状确实被血管硬化直接塑造:Milkovich 等人提出”谐波畸变指数”(基频以上能量与基频能量的比值),在小鼠身上证明该指数随收缩压线性下降、并与主动脉切线模量和脉搏波速度(PWV)显著线性相关——动脉越硬,谐波能量分布系统性改变(PMID 35433650)。其次,人体流行病学证据把”硬化→波形改变”钉得更死:Framingham 子代队列中,年龄是颈股 PWV 的最强相关变量(模型 R²=0.512),衰老使主动脉硬度增加、反射波提前返回,增强指数随年龄单调上升(PMID 15123572);颈股 PWV 又独立预测收缩压的纵向升高与高血压发病(HR 1.10/每 1 m/s)(PMID 18387440)。这些证据意味着:一个人从青年到老年的谐波谱改变,绝大部分可能只是”动脉老化”这一全局过程,而与该时刻哪个脏腑”虚”了毫无关系。

但若因此就把器官共振假说一棒打死,又过于草率——因为硬化路径与共振路径在频域上并非不可分离。Segers 团队在 2026 名健康中年人中做了阻抗谱分析,发现年龄相关的 PWV 增加(6.1→7.0 m/s,+15%)并不完全平行于输入阻抗的变化:女性总动脉顺应性下降导致低频输入阻抗升高,男性特征阻抗反而随年龄下降——”硬化增加”与”阻抗增加”是两回事(PMID 17404183)。用磁共振同步测量升主动脉流速与颈动脉压力、做时频域阻抗谱,同样显示不同年龄段的阻抗相位谱有独立于硬化的结构变化(PMID 27054528)。也就是说:在频域上,”全局硬化信号”和”器官/血管床特异信号”确实占据不同的频带与相位结构,理论上可以拆分。

这正是本课题的机制拆分设计:对同一批受试者同步采集三类数据——①颈股 PWV(硬化金标准)+ 增强指数(波反射强度)(PMID 9883745、15683725);②桡动脉压力波形 FFT 得到的谐波能量谱 C1-C10;③器官供血动脉几何(衔接 #268 的 1-D 模型预测)。分析上做三层方差分解:第一步,全样本回归谐波能量谱对 PWV/AIx 的依赖,量化”硬化+后负荷”解释的方差比例;第二步,把回归残差拿出来,检验控制硬化后是否仍存在与年龄/疾病无关的稳定谐波结构(器官共振的独立证据);第三步,跨疾病验证——在糖尿病、高血压、单纯老化三组人群中,残差结构是否一致,若三组残差各不相同,说明存在疾病特异而非单纯硬化的谐波信号。

三种结局都是知识。结局一(硬化主导):若 PWV/AIx 能解释谐波谱 70% 以上的方差且残差无稳定结构,”谐波-脏腑”对应需要被重新表述为”谐波-血管老化状态”,中医脉诊的频域化必须把年龄/硬化作为首要协变量,否则一切”脏腑辨证”都是统计伪影。结局二(共振保留):若控制硬化后残差仍稳定存在且跨疾病一致,”一脏一谐波”获得独立于全局背景的关键证据,机制拆分完成。结局三(共线纠缠):若两条路径高度共线无法分离,则需要补充干预实验——用降压药/扩血管药改变后负荷后观察谐波谱是否独立变化(后负荷敏感即硬化路径,不敏感即共振路径),这是最后的分离手段。

这个设计的最大价值,是把”谐波谱测的是什么”从一个信仰问题变成一个可量化的方差分解问题。它与 #268 构成互补:前者问”器官几何能否预测谐波分配”(正方向),本篇问”谐波改变有多少被全局硬化解释”(反方向)——两条路合起来,才可能把王唯工的”一脏一谐波”从”听起来很美”推进到”算得出来、拆得开”。

证据与局限

已验证: 谐波畸变指数随动脉硬化(切线模量/PWV)线性变化(PMID 35433650);T2DM 患者桡动脉谐波指数 C1/C5 显著偏移(PMID 32733859);年龄是 PWV 的最强相关变量、增强指数随年龄上升(PMID 15123572);PWV 独立预测收缩压升高与高血压发病(PMID 18387440);PWV 增加不完全平行于阻抗增加(PMID 17404183);磁共振时频域阻抗谱显示独立于硬化的结构变化(PMID 27054528);波反射强度与左室肥厚相关(PMID 11016799)。

部分验证: “硬化+后负荷”对谐波谱方差的贡献比例从未被系统量化——现有文献只报告相关显著,不做方差分解;控制硬化后的谐波残差是否存在稳定结构,无直接研究。

待验证: ① 全样本中 PWV/AIx 解释谐波能量谱方差的具体比例(70%?50%?);② 控制硬化后残差谐波结构的跨疾病一致性(糖尿病/高血压/老化三组);③ 药物改变后负荷后谐波谱的独立变化(干预分离试验)。

相关阅读

证据等级: B
参考文献: PMID 35433650, PMID 32733859, PMID 18387440, PMID 15123572, PMID 17404183, PMID 27054528, PMID 9883745


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

To what extent can harmonic shifts be explained by ‘vascular stiffening/afterload’ rather than ‘organ resonance’: a mechanism-dissected study

Evidence level: B

Every alteration in the pulse diagnosis harmonic spectrum (C1-C10) may merely represent global “background noise” driven by vascular stiffening and afterload. To validate the existence of a genuine “one organ, one harmonic” phenomenon, the contribution ratios of these two pathways must first be quantified.

Main Text

A hidden vulnerability in the frequency-domain research of Traditional Chinese Medicine (TCM) pulse diagnosis is that while the harmonic components of the radial artery pulse wave (harmonics C1 through C10) do carry disease information—such as significant shifts in C1 and C5 in diabetic patients (PMID 32733859) or the utility of harmonic energy ratios in distinguishing coronary heart disease—a change in harmonics does not equate to dysfunction in a corresponding organ. The pulse wave is the composite pressure wave generated by cardiac ejection, propagating along the arterial tree and superimposing with reflected waves. Its spectral shape is jointly determined by three factors: ① the intrinsic mechanical properties of the vessel wall (elasticity/stiffness, i.e., the “vascular stiffening” pathway); ② the structural coupling between ventricular ejection and the arterial tree producing “afterload/wave reflection” characteristics (reflected wave intensity and return timing); and ③ the frequency selectivity of the vascular beds supplying each organ (i.e., the “organ resonance” pathway). The first two are global, monotonically changing “backgrounds” influenced by age and disease; the third constitutes the “organ-specific foreground” upon which the “one organ, one harmonic” hypothesis relies.

The issue is that existing literature almost exclusively reports significant correlations between the harmonic spectrum and specific diseases without ever dissecting the contribution ratios of these three factors. This leads to a sharp alternative explanation: if the majority of harmonic spectrum variability is actually driven by vascular stiffening and afterload, then “harmonic-organ correspondence” may merely be an artifact of “harmonic-vessel aging,” requiring a significant downgrade of the organ resonance hypothesis.

The evidence chain for this “counter-argument” pathway is remarkably robust. First, the global shape of the harmonic spectrum is indeed directly sculpted by vascular stiffening: Milkovich et al. proposed a “harmonic distortion index” (the ratio of energy above the fundamental frequency to the fundamental frequency energy), demonstrating in mice that this index decreases linearly with systolic blood pressure and correlates significantly linearly with aortic tangent modulus and pulse wave velocity (PWV)—harder arteries lead to systematic changes in harmonic energy distribution (PMID 35433650). Second, human epidemiological evidence locks down the “stiffening→waveform alteration” link: in the Framingham offspring cohort, age is the strongest correlate of carotid-femoral PWV (model R²=0.512); aging increases aortic stiffness and causes earlier return of reflected waves, causing the index to rise monotonically with age (PMID 15123572); carotid-femoral PWV independently predicts longitudinal increases in systolic blood pressure and the incidence of hypertension (HR 1.10 per 1 m/s) (PMID 18387440). These findings imply that the alteration of an individual’s harmonic spectrum from youth to old age may be attributable largely to this global process of “arterial aging,” having little relation to which organ is “deficient” at that moment.

However, dismissing the organ resonance hypothesis outright based on this would be overly hasty, as the stiffening pathway and the resonance pathway are not entirely separable in the frequency domain. Segers et al. conducted impedance spectrum analysis in 2,026 healthy middle-aged adults and found that age-related increases in PWV (6.1→7.0 m/s, +15%) do not fully parallel changes in input impedance: total arterial compliance decreases in females leading to elevated low-frequency input impedance, whereas characteristic impedance in males actually declines with age—”increased stiffening” and “increased impedance” are distinct phenomena (PMID 17404183). Similarly, simultaneous MRI measurements of ascending aortic flow velocity and carotid pressure with time-frequency domain impedance spectra reveal structural changes in impedance phase spectra across different age groups independent of stiffening (PMID 27054528). In other words, in the frequency domain, “global stiffening signals” and “organ/vascular bed-specific signals” indeed occupy different frequency bands and phase structures, theoretically allowing for separation.

This is precisely the mechanism dissection design of this study: synchronously collecting three types of data from the same cohort—① carotid-femoral PWV (gold standard for stiffening) + enhancement index (wave reflection intensity) (PMID 9883745, 15683725); ② harmonic energy spectrum C1-C10 derived from FFT of radial artery pressure waves; and ③ geometric parameters of organ-supplying arteries (predicted by the 1-D model referenced in #268). The analysis employs a three-layer variance decomposition: Step 1, regress the harmonic energy spectrum against PWV/AIx in the full sample to quantify the variance proportion explained by “stiffening + afterload”; Step 2, extract regression residuals to test whether a stable harmonic structure persists independent of age and disease after controlling for stiffening (independent evidence for organ resonance); Step 3, cross-disease validation—whether the residual structure is consistent across diabetic, hypertensive, and aging-only groups. If the residuals differ significantly across these three groups, it indicates disease-specific rather than purely stiffening-driven harmonic signals.

All three outcomes represent valid knowledge. Outcome 1 (Stiffing Dominance): If PWV/AIx explains over 70% of the variance in the harmonic spectrum and residuals show no stable structure, “harmonic-organ” correspondence must be rephrased as “harmonic-vessel aging status.” Frequency-domain TCM pulse diagnosis must treat age/stiffening as primary covariates; otherwise, all “organ differentiation” becomes statistical artifact. Outcome 2 (Resonance Retained): If stable residuals persist after controlling for stiffening and remain consistent across diseases, the “one organ, one harmonic” hypothesis gains key evidence independent of global backgrounds, completing the mechanism dissection. Outcome 3 (Collinear Entanglement): If the two pathways are highly collinear and inseparable, supplementary intervention experiments are needed—altering afterload using antihypertensives or vasodilators and observing independent changes in the harmonic spectrum (sensitivity to afterload indicates the stiffening pathway; insensitivity indicates the resonance pathway), serving as the final separation method.

The greatest value of this design is transforming “what does the harmonic spectrum measure” from a matter of faith into a quantifiable variance decomposition problem. It complements #268: the former asks whether organ geometry can predict harmonic allocation (positive direction), while this study asks how much harmonic alteration is explained by global stiffening (negative direction). Together, these two approaches may advance Wang Weigong’s “one organ, one harmonic” from “sounds beautiful” to “calculable and separable.”

Evidence and Limitations

Verified: Harmonic distortion index changes linearly with arterial stiffening (tangent modulus/PWV) (PMID 35433650); radial artery harmonic index C1/C5 shows significant shift in T2DM patients (PMID 32733859); age is the strongest correlate of PWV, and enhancement index rises with age (PMID 15123572); PWV independently predicts systolic blood pressure elevation and hypertension incidence (PMID 18387440); PWV increase does not fully parallel impedance increase (PMID 17404183); time-frequency domain impedance spectra from MRI show structural changes independent of stiffening (PMID 27054528); wave reflection intensity correlates with left ventricular hypertrophy (PMID 11016799).

Partially Verified: The contribution proportion of “stiffening + afterload” to harmonic spectrum variance has never been systematically quantified—existing literature reports only significant correlations without variance decomposition; no direct study exists on whether stable harmonic residual structures exist after controlling for stiffening.

To Be Verified: ① The specific proportion of variance in harmonic energy spectrum explained by PWV/AIx in the full sample (70%? 50%?); ② Cross-disease consistency of residual harmonic structures after controlling for stiffening (diabetes/hypertension/aging groups); ③ Independent changes in the harmonic spectrum following drug-induced alterations in afterload (intervention separation trial).

Related Reading

Evidence Level: B
References: PMID 35433650, PMID 32733859, PMID 18387440, PMID 15123572, PMID 17404183, PMID 27054528, PMID 9883745


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *